Clinical trial / 2019
Dietary consumption of palm fat containing glycidyl esters increased hemoglobin adduct 2,3-diHOPr-Val levels in healthy humans.
Eleven healthy participants consumed about 36 g/day of commercially available palm fat containing ester-bound glycidol (8.7 mg/kg) for 4 weeks, with blood monitored over 15 weeks. Mean 2,3-diHOPr-Val adduct levels increased from 4.0 to 12.2 pmol/g hemoglobin. The mean adduct level/dose ratio was 0.082 pmol 2,3-diHOPr-Val/g hemoglobin per µg glycidol/kg body weight, and mean adduct lifetime was 104 days. Based on background levels, mean external glycidol exposure was estimated at 0.94 µg/kg body weight, which is higher than current food occurrence and consumption estimates.
- Study type
- Controlled exposure study
- Who was studied
- 11 healthy participants
- What was measured
- Hemoglobin adduct N-(2,3-dihydroxypropyl)-valine (2,3-diHOPr-Val) levels over 15 weeks
THE PAPER
The hemoglobin adduct N-(2,3-dihydroxypropyl)-valine as biomarker of dietary exposure to glycidyl esters: a controlled exposure study in humans.
Abraham K, Hielscher J, Kaufholz T, Mielke H, Lampen A, Monien B. Arch Toxicol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.